Finance

Lists
300601:SHE
Shenzhen Kangtai Biological Prods Co Ltd
12,43 CNY
-0,56%
(-0,070) 1D
16 ოქტ, 15:04:19 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300601...
Open
12,59 CNY
High
13,00 CNY
Low
12,30 CNY
Mkt. cap
14,45 მლრდ.
Avg. vol.
19,76 მლნ.
Volume
20,15 მლნ.
P/E ratio
165,53
52-wk high
17,76 CNY
52-wk low
10,70 CNY
EPS
0,08 CNY
Shares outstanding
1,12 მლრდ.
No. of employees
2 ათ.
Open
12,59 CNY
High
13,00 CNY
Low
12,30 CNY
Mkt. cap
14,45 მლრდ.
Avg. vol.
19,76 მლნ.
Volume
20,15 მლნ.
P/E ratio
165,53
52-wk high
17,76 CNY
52-wk low
10,70 CNY
EPS
0,08 CNY
Shares outstanding
1,12 მლრდ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Profile
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products. Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
About Shenzhen Kangtai Biological Prods Co Ltd
CEO-
Employees1,96 ათ.
Founded8 სექ. 1992
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
671,38 მლნ.
609,64 მლნ.
631,11 მლნ.
641,89 მლნ.
Cost of goods sold
110,97 მლნ.
267,74 მლნ.
182,40 მლნ.
218,78 მლნ.
Cost of revenue
110,97 მლნ.
267,74 მლნ.
182,40 მლნ.
218,78 მლნ.
Research and development expenses
123,15 მლნ.
123,35 მლნ.
84,28 მლნ.
90,88 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
291,37 მლნ.
283,35 მლნ.
302,79 მლნ.
284,34 მლნ.
Operating expense
425,29 მლნ.
428,59 მლნ.
406,24 მლნ.
402,08 მლნ.
Total operating expenses
536,26 მლნ.
696,33 მლნ.
588,65 მლნ.
620,87 მლნ.
Operating income
135,12 მლნ.
-86,69 მლნ.
42,47 მლნ.
21,03 მლნ.
Other non operating income
-375,71 ათ.
308,38 ათ.
-2,04 მლნ.
1,69 მლნ.
EBT including unusual items
324,22 ათ.
45,26 მლნ.
39,95 მლნ.
1,37 მლნ.
EBT excluding unusual items
125,91 მლნ.
-104,26 მლნ.
19,66 მლნ.
-1,09 მლნ.
Income tax expense
-11,26 მლნ.
24,17 მლნ.
6,35 მლნ.
-12,75 მლნ.
Effective tax rate
-3 472,08%
53,40%
15,89%
-932,00%
Other operating expenses
3,89 მლნ.
14,05 მლნ.
6,96 მლნ.
12,14 მლნ.
Net income
11,62 მლნ.
21,17 მლნ.
33,34 მლნ.
17,05 მლნ.
Net profit margin
1,73%
3,47%
5,28%
2,66%
Earnings per share
-
-
-
-
Interest and investment income
20,88 მლნ.
13,75 მლნ.
8,72 მლნ.
9,41 მლნ.
Interest expense
-30,13 მლნ.
-30,16 მლნ.
-29,50 მლნ.
-29,76 მლნ.
Net interest expenses
-9,24 მლნ.
-16,42 მლნ.
-20,77 მლნ.
-20,35 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
212,79 მლნ.
11,74 მლნ.
140,90 მლნ.
126,83 მლნ.
Gain or loss from assets sale
-365,90 ათ.
934,47 ათ.
-
-5,69 ათ.
AI content may include mistakes. Learn more
Google აპები